ERBB2 and neoplasm: In this work, we develop stimuli-sensitive tumor-targeted photodynamic nanoparticles (STPNs) consisting of UCNPs, stimuli-responsive polymeric ligands (SPLs), and trastuzumab (TZB), for HER2-targeted GBC therapy (Fig. 1a).